I A Global Asset Management Inc. Cytokinetics Inc Transaction History

I A Global Asset Management Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 15, 2023	SELL	$29.46 - $36.61 $143,764 - $178,656	-4,880 Reduced 9.27%	47,750 $1.41 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $1.72 Million - $2.14 Million	52,630 New	52,630 $1.72 Million

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.6B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of I A Global Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on I A Global Asset Management Inc. with notifications on news.